Minerva Neurosciences stock rises 7% on plans to advance schizophrenia drug to late-stage trials

http://www.marketwatch.com/story/minerva-neurosciences-stock-rises-7-on-plans-to-advance-schizophrenia-drug-to-late-stage-trials-2017-05-15

2 Likes

good to see this …!!! Sup everhopeful …!!!

1 Like

I hope this med is good

2 Likes